REICHLING STEVEN 4
4 · Accelerate Diagnostics, Inc · Filed Jan 17, 2023
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-01-13$0.69/sh−4,730$3,264→ 72,202 total - Exercise/Conversion
Common Stock
2023-01-13+9,439→ 76,932 total - Exercise/Conversion
Employee Restricted Stock Units
2023-01-13−9,439→ 0 total→ Common Stock (9,439 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 113,265 restricted stock units, which vests in equal amounts every month for 12 months.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.